Prednisolone priming enhances Th1 response and efficacy of subsequent lamivudine therapy in patients with chronic hepatitis B

Hepatology

Volumn 32, Issue 3, 2000, Pages 604-609

  Liaw, Yun Fan ^a   Tsai, Sun Lung ^a   Chien, Rong Nan ^a   Yeh, Chau Ting ^a   Chu, Chia Ming ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B CORE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; PREDNISOLONE; RECOMBINANT PROTEIN; VIRUS DNA;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CELL PROLIFERATION; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG RESPONSE; FEMALE; HELPER CELL; HEPATITIS B; HUMAN; HUMAN CELL; MALE; MONOCYTE; PRIORITY JOURNAL; REBOUND; SEROCONVERSION; STEROID THERAPY;

EID: 0033844153     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.9717     Document Type: Article

References (28)

1. Present and future directions in the treatment of chronic hepatitis B infection
2. Lamivudine therapy of WHV-infected woodchucks
3. A preliminary trial of lamivudine for chronic hepatitis B infection
4. Lamivudine therapy for chronic hepatitis B: A six-month randomized dose-ranging study
5. A one year trial of lamividine for chronic hepatitis B
6. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B
7. Drug therapy for chronic hepatitis B: Antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy
8. Lamivudine as initial treatment for chronic hepatitis B in the United States
9. Pretherapy alanine aminotransferase level as a determinant for HBeAg seroconversion during lamivudine therapy in patients with chronic hepatitis B
10. Pathogenesis and clinical significance of acute exacerbations and remissions in patients with chronic hepatitis B virus infection
11. Hepatitis viruses under immunosuppressive agents
12. Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B: A controlled study
13. A randomized, controlled trial of interferon alfa-2b alone and after prednisolone withdrawal for the treatment of chronic hepatitis B
14. Prednisolone-interferon combination in the treatment of chronic hepatitis B: Direct and indirect metanalysis
15. Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B
16. Current trends in therapy for chronic viral hepatitis
17. Dramatic response to lamivudine therapy following corticosteroid priming in chronic hepatitis B
18. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy
19. Comparison of two methods for quantitation of hepatitis B viral DNA
20. Acute exacerbation of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens: Implication for hepatitis B e antigen seroconversion
21. A model for the hepatitis B virus core protein: Prediction of antigen sites and relationship to RNA virus capsid proteins
22. Detection of type 2-like T-helper cells in hepatitis C virus infection: Implications for hepatitis C virus chronicity
23. Selective expression of an interleukin-12 receptor component by human T helper 1 cells
24. Severe clinical rebound upon withdrawal of corticosteroid before interferon therapy: Incidence and risk factors
25. Lack of effect of antiviral therapy in non-dividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus
26. The expanding universe of T-cell subsets: Th1, Th2 and more
27. What once was lost, now is found: Restoration of hepatitis B-specific immunity after treatment of chronic hepatitis B
28. Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: A randomized trial